Cargando…
The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey
INTRODUCTION: In 2017, amidst insecurity and displacements posed by Boko Haram armed insurgency, cholera outbreak started in the Muna Garage camp for Internally Displaced Persons (IDPs) in Borno State, Nigeria. In response, the Borno Ministry of Health and partners determined to provide oral cholera...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326259/ https://www.ncbi.nlm.nih.gov/pubmed/32601092 http://dx.doi.org/10.1136/bmjgh-2020-002431 |
_version_ | 1783552313930022912 |
---|---|
author | Ngwa, Moise Chi Alemu, Wondimagegnehu Okudo, Ifeanyi Owili, Collins Ugochukwu, Uzoma Clement, Peter Devaux, Isabelle Pezzoli, Lorenzo Oche, James Agada Ihekweazu, Chikwe Sack, David A |
author_facet | Ngwa, Moise Chi Alemu, Wondimagegnehu Okudo, Ifeanyi Owili, Collins Ugochukwu, Uzoma Clement, Peter Devaux, Isabelle Pezzoli, Lorenzo Oche, James Agada Ihekweazu, Chikwe Sack, David A |
author_sort | Ngwa, Moise Chi |
collection | PubMed |
description | INTRODUCTION: In 2017, amidst insecurity and displacements posed by Boko Haram armed insurgency, cholera outbreak started in the Muna Garage camp for Internally Displaced Persons (IDPs) in Borno State, Nigeria. In response, the Borno Ministry of Health and partners determined to provide oral cholera vaccine (OCV) to about 1 million people in IDP camps and surrounding communities in six Local Government Areas (LGAs) including Maiduguri, Jere, Konduga, Mafa, Dikwa, and Monguno. As part of Monitoring and Evaluation, we described the coverage achieved, adverse events following immunisation (AEFI), non-vaccination reasons, vaccination decisions as well as campaign information sources. METHODS: We conducted two-stage probability cluster surveys with clusters selected without replacement according to probability-proportionate-to-population-size in the six LGAs targeted by the campaign. Individuals aged ≥1 years were the eligible study population. Data sources were household interviews with vaccine card verification and memory recall, if no card, as well as multiple choice questions with an open-ended option. RESULTS: Overall, 12 931 respondents participated in the survey. Overall, 90% (95% CI: 88 to 92) of the target population received at least one dose of OCV, range 87% (95% CI: 75 to 94) in Maiduguri to 94% (95% CI: 88 to 97) in Monguno. The weighted two-dose coverage was 73% (95% CI: 68 to 77) with a low of 68% (95% CI: 46 to 86) in Maiduguri to a high of 87% (95% CI: 74 to 95) in Dikwa. The coverage was lower during first round (76%, 95% CI: 71 to 80) than second round (87%, 95% CI: 84 to 89) and ranged from 72% (95% CI: 42 to 89) and 82% (95% CI: 82 to 91) in Maiduguri to 87% (95% CI: 75 to 95) and 94% (95% CI: 88 to 97) in Dikwa for the respective first and second rounds. Also, coverage was higher among females of age 5 to 14 and ≥15 years than males of same age groups. There were mild AEFI with the most common symptoms being fever, headache and diarrhoea occurring up to 48 hours after ingesting the vaccine. The most common actions taken after AEFI symptoms included ‘did nothing’ and ‘self-medicated at home’. The top reason for taking vaccine was to protect from cholera while top reason for non-vaccination was travel/work. The main source of campaign information was a neighbour. An overwhelming majority (96%, 95% CI: 95% to 98%) felt the campaign team treated them with respect. While 43% (95% CI: 36% to 50%) asked no questions, 37% (95% CI: 31% to 44%) felt the team addressed all their concerns. CONCLUSION: The campaign achieved high coverage using door-to-door and fixed sites strategies amidst insecurity posed by Boko Haram. Additional studies are needed to improve how to reduce non-vaccination, especially for the first round. While OCV provides protection for a few years, additional actions will be needed to make investments in water, sanitation and hygiene infrastructure. |
format | Online Article Text |
id | pubmed-7326259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-73262592020-07-02 The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey Ngwa, Moise Chi Alemu, Wondimagegnehu Okudo, Ifeanyi Owili, Collins Ugochukwu, Uzoma Clement, Peter Devaux, Isabelle Pezzoli, Lorenzo Oche, James Agada Ihekweazu, Chikwe Sack, David A BMJ Glob Health Original Research INTRODUCTION: In 2017, amidst insecurity and displacements posed by Boko Haram armed insurgency, cholera outbreak started in the Muna Garage camp for Internally Displaced Persons (IDPs) in Borno State, Nigeria. In response, the Borno Ministry of Health and partners determined to provide oral cholera vaccine (OCV) to about 1 million people in IDP camps and surrounding communities in six Local Government Areas (LGAs) including Maiduguri, Jere, Konduga, Mafa, Dikwa, and Monguno. As part of Monitoring and Evaluation, we described the coverage achieved, adverse events following immunisation (AEFI), non-vaccination reasons, vaccination decisions as well as campaign information sources. METHODS: We conducted two-stage probability cluster surveys with clusters selected without replacement according to probability-proportionate-to-population-size in the six LGAs targeted by the campaign. Individuals aged ≥1 years were the eligible study population. Data sources were household interviews with vaccine card verification and memory recall, if no card, as well as multiple choice questions with an open-ended option. RESULTS: Overall, 12 931 respondents participated in the survey. Overall, 90% (95% CI: 88 to 92) of the target population received at least one dose of OCV, range 87% (95% CI: 75 to 94) in Maiduguri to 94% (95% CI: 88 to 97) in Monguno. The weighted two-dose coverage was 73% (95% CI: 68 to 77) with a low of 68% (95% CI: 46 to 86) in Maiduguri to a high of 87% (95% CI: 74 to 95) in Dikwa. The coverage was lower during first round (76%, 95% CI: 71 to 80) than second round (87%, 95% CI: 84 to 89) and ranged from 72% (95% CI: 42 to 89) and 82% (95% CI: 82 to 91) in Maiduguri to 87% (95% CI: 75 to 95) and 94% (95% CI: 88 to 97) in Dikwa for the respective first and second rounds. Also, coverage was higher among females of age 5 to 14 and ≥15 years than males of same age groups. There were mild AEFI with the most common symptoms being fever, headache and diarrhoea occurring up to 48 hours after ingesting the vaccine. The most common actions taken after AEFI symptoms included ‘did nothing’ and ‘self-medicated at home’. The top reason for taking vaccine was to protect from cholera while top reason for non-vaccination was travel/work. The main source of campaign information was a neighbour. An overwhelming majority (96%, 95% CI: 95% to 98%) felt the campaign team treated them with respect. While 43% (95% CI: 36% to 50%) asked no questions, 37% (95% CI: 31% to 44%) felt the team addressed all their concerns. CONCLUSION: The campaign achieved high coverage using door-to-door and fixed sites strategies amidst insecurity posed by Boko Haram. Additional studies are needed to improve how to reduce non-vaccination, especially for the first round. While OCV provides protection for a few years, additional actions will be needed to make investments in water, sanitation and hygiene infrastructure. BMJ Publishing Group 2020-06-29 /pmc/articles/PMC7326259/ /pubmed/32601092 http://dx.doi.org/10.1136/bmjgh-2020-002431 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Research Ngwa, Moise Chi Alemu, Wondimagegnehu Okudo, Ifeanyi Owili, Collins Ugochukwu, Uzoma Clement, Peter Devaux, Isabelle Pezzoli, Lorenzo Oche, James Agada Ihekweazu, Chikwe Sack, David A The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey |
title | The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey |
title_full | The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey |
title_fullStr | The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey |
title_full_unstemmed | The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey |
title_short | The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey |
title_sort | reactive vaccination campaign against cholera emergency in camps for internally displaced persons, borno, nigeria, 2017: a two-stage cluster survey |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326259/ https://www.ncbi.nlm.nih.gov/pubmed/32601092 http://dx.doi.org/10.1136/bmjgh-2020-002431 |
work_keys_str_mv | AT ngwamoisechi thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT alemuwondimagegnehu thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT okudoifeanyi thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT owilicollins thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT ugochukwuuzoma thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT clementpeter thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT devauxisabelle thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT pezzolilorenzo thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT ochejamesagada thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT ihekweazuchikwe thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT sackdavida thereactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT ngwamoisechi reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT alemuwondimagegnehu reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT okudoifeanyi reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT owilicollins reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT ugochukwuuzoma reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT clementpeter reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT devauxisabelle reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT pezzolilorenzo reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT ochejamesagada reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT ihekweazuchikwe reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey AT sackdavida reactivevaccinationcampaignagainstcholeraemergencyincampsforinternallydisplacedpersonsbornonigeria2017atwostageclustersurvey |